Moreover, while elevated levels of tumor-infiltrating cytotoxic T cells (CTLs) are associated with improved prognosis and outcomes of CRC [11], limited studies have reported a significant association between CD4+ T cell infiltration and survival; possibly attributing it to the different subsets and heterogeneity of CD4+ T cell populations [12]. The gene discussed is CD4; the disease is neoplasm.